Open an account

Alpha Teknova

TKNO · NASDAQ

$7.39+$0.59 (+8.68%)TodayMarket closed ·
Prev close $6.80

About TKNO

Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 158 full-time employees. The company went IPO on 2021-06-25. The firm offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.

Employees
158
Headquarters
Hollister, California
Listed
Jun 25, 2021
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
teknova.com

TKNO key statistics

Market cap
396.76M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
316.33K
Volume
480.94K
Open price
$6.81
High today
$7.67
Low today
$6.78
52 Week high
$9.48
52 Week low
$1.91

Alpha Teknova (TKNO) at a glance

As of Oct 20, 2026, Alpha Teknova (TKNO) shares are priced at $7.39, giving the company a market cap of 396.76M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $6.78 and $7.67. The current price is 9.0% above the day's low and 3.7% below its high.

Volume so far is 480.94K shares, above the average of 316.33K shares a day.

Over the past year Alpha Teknova has ranged from $1.91 to $9.48, and now sits 72% of the way up that range.

Alpha Teknova met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.06 per share against an estimate of -$0.0884.

The average analyst price target is $9.18, 24.2% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 8 analystsAvg $9.18
Low
$7.07
Now
$7.39
High
$12.60

TKNO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 18.0% on average.

  1. Q3 FY24: reported -$0.15 per share against an estimate of -$0.1148
  2. Q4 FY24: reported -$0.11 per share against an estimate of -$0.1224
  3. Q1 FY25: reported -$0.09 per share against an estimate of -$0.1088
  4. Q2 FY25: reported -$0.07 per share against an estimate of -$0.102
  5. Q3 FY25: reported -$0.08 per share against an estimate of -$0.0959
  6. Q4 FY25: reported -$0.09 per share against an estimate of -$0.0938
  7. Q1 FY26: reported -$0.08 per share against an estimate of -$0.0938
  8. Q2 FY26: reported -$0.06 per share against an estimate of -$0.0884

TKNO news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Earnings Scheduled For November 6, 2025

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Earnings Scheduled For May 8, 2025

  • Avi Kapoor

    J.B. Hunt Transport Posts Lower Profit, Joins ASML, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • Avi Kapoor

    Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as Alpha Teknova

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.